Beam Therapeutics shows promise in gene therapy for sickle cell disease, but it also has high risks and market expectations.

Switching from a conventional to a high-sensitivity cardiac troponin assay was linked to lower mortality at 30 days and 1 ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been ...

When is food simply nourishing and enjoyable, and when does it provoke an allergic reaction? The answer appears to lie in the ...

NerdWallet's list of the best high-yield savings accounts. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on ...

Huge prizes up for grabs in January! Jan Slam is back for 2025 - find out more. Chappell Roan - exclusive Sound of 2025 interview Chappell Roan reflects on the last 12 months in an extensive chat ...